Status:
COMPLETED
Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations
Lead Sponsor:
Kaiser Permanente
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this pilot and feasibility study, the investigator will randomize 100 African-American, Hispanic, and/or Medicaid (all race/ethnicities) patients from KPNW with A1C ≥ 8 to one of two 6-month interv...
Detailed Description
The purpose of this feasibility study is to inform the design of a future large-scale, randomized trial that will test if there is added benefit to addressing both social and economic needs and diabet...
Eligibility Criteria
Inclusion
- Diabetes diagnosis
- Current Kaiser Permanente Northwest member
- African-American, Hispanic/Latino (English, Spanish-speaking, or bilingual), and/or a Medicaid recipient (from any racial or ethnic background)
- Age 18 or older
- Most recent hemoglobin A1C test of ≥ 8
- Endorses 1 or more social and/or economic need on the Your Current Life Situation assessment
Exclusion
- Patients who are unable to provide informed consent due to cognitive or psychiatric impairment.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03802825
Start Date
March 1 2019
End Date
June 30 2021
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northwest
Portland, Oregon, United States, 97227